Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Jun;7(6):2196-200.
doi: 10.1128/mcb.7.6.2196-2200.1987.

Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidine

Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidine

D Samid et al. Mol Cell Biol. 1987 Jun.

Abstract

Prolonged alpha/beta interferon (IFN-alpha/beta) treatment of NIH 3T3 cells transformed by a long terminal repeat-activated Ha-ras proto-oncogene resulted in revertants that maintained a nontransformed phenotype long after IFN treatment had been discontinued. Cloned persistent revertants (PRs) produced large amounts of the ras-encoded p21 and were refractile to transformation by EJras DNA and by transforming retroviruses which carried the v-Ha-ras, v-Ki-ras, v-abl, or v-fes oncogene. Transient treatment either in vitro or in vivo with cytidine analogs that alter gene expression by inhibiting DNA methylation resulted in transformation of PR, but not of NIH 3T3, cells. The PR retransformants reverted again with IFN, suggesting that DNA methylation is involved in IFN-induced persistent reversion.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cell. 1984 Oct;38(3):745-55 - PubMed
    1. Int J Cancer. 1984 Jul 15;34(1):107-12 - PubMed
    1. Biochem Biophys Res Commun. 1985 Jan 16;126(1):509-16 - PubMed
    1. Proc Natl Acad Sci U S A. 1985 Apr;82(7):2062-6 - PubMed
    1. Mol Cell Biol. 1985 Jul;5(7):1800-3 - PubMed

Publication types